JP4346438B2 - 緑内障および老眼の治療のための方法および強膜内インプラント - Google Patents

緑内障および老眼の治療のための方法および強膜内インプラント Download PDF

Info

Publication number: JP4346438B2
Authority: JP; Japan
Prior art keywords: implant; body portion; intrascleral; medication; reservoir
Prior art date: 2001-08-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

JP2003520429A

Other languages

English (en)

Japanese (ja)

Other versions

JP2005508213A (ja

Inventor

キャスティルジョス，デービッド

Original Assignee

グローコマリサーチテクノロジーズ，インコーポレイティッド

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-03

Filing date

2002-08-02

Publication date

2009-10-21

2002-08-02 Application filed by グローコマリサーチテクノロジーズ，インコーポレイティッド filed Critical グローコマリサーチテクノロジーズ，インコーポレイティッド

2005-03-31 Publication of JP2005508213A publication Critical patent/JP2005508213A/ja

2009-10-21 Application granted granted Critical

2009-10-21 Publication of JP4346438B2 publication Critical patent/JP4346438B2/ja

2022-08-02 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

239000007943 implant Substances 0.000 title claims description 83
201000010041 presbyopia Diseases 0.000 title claims description 15
238000000034 method Methods 0.000 title description 22
238000011282 treatment Methods 0.000 title description 9
208000010412 Glaucoma Diseases 0.000 title description 7
239000003814 drug Substances 0.000 claims description 29
229940079593 drug Drugs 0.000 claims description 24
230000004410 intraocular pressure Effects 0.000 claims description 22
210000003786 sclera Anatomy 0.000 claims description 22
238000000576 coating method Methods 0.000 claims description 7
238000002513 implantation Methods 0.000 claims description 7
239000011248 coating agent Substances 0.000 claims description 6
210000001508 eye Anatomy 0.000 description 52
230000004438 eyesight Effects 0.000 description 15
239000012530 fluid Substances 0.000 description 9
201000004569 Blindness Diseases 0.000 description 8
239000000463 material Substances 0.000 description 8
238000001356 surgical procedure Methods 0.000 description 8
230000001886 ciliary effect Effects 0.000 description 7
210000004087 cornea Anatomy 0.000 description 7
210000003205 muscle Anatomy 0.000 description 7
210000002159 anterior chamber Anatomy 0.000 description 6
210000001519 tissue Anatomy 0.000 description 6
238000012377 drug delivery Methods 0.000 description 5
230000007774 longterm Effects 0.000 description 5
238000004891 communication Methods 0.000 description 4
230000000694 effects Effects 0.000 description 3
208000030533 eye disease Diseases 0.000 description 3
NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
230000003466 anti-cipated effect Effects 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
239000011521 glass Substances 0.000 description 2
229910052588 hydroxylapatite Inorganic materials 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
238000002430 laser surgery Methods 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
239000004926 polymethyl methacrylate Substances 0.000 description 2
229920001296 polysiloxane Polymers 0.000 description 2
210000001747 pupil Anatomy 0.000 description 2
229910052715 tantalum Inorganic materials 0.000 description 2
GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 2
ZYSIKFURCZVRMP-UHFFFAOYSA-N CS1CCCC1 Chemical compound CS1CCCC1 ZYSIKFURCZVRMP-UHFFFAOYSA-N 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
238000004873 anchoring Methods 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
210000005252 bulbus oculi Anatomy 0.000 description 1
210000000795 conjunctiva Anatomy 0.000 description 1
238000012937 correction Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
238000005553 drilling Methods 0.000 description 1
230000004406 elevated intraocular pressure Effects 0.000 description 1
231100000040 eye damage Toxicity 0.000 description 1
210000000744 eyelid Anatomy 0.000 description 1
238000001914 filtration Methods 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
238000002386 leaching Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
208000018769 loss of vision Diseases 0.000 description 1
231100000864 loss of vision Toxicity 0.000 description 1
210000004877 mucosa Anatomy 0.000 description 1
201000001119 neuropathy Diseases 0.000 description 1
230000007823 neuropathy Effects 0.000 description 1
210000001328 optic nerve Anatomy 0.000 description 1
208000033808 peripheral neuropathy Diseases 0.000 description 1
239000000049 pigment Substances 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
210000001525 retina Anatomy 0.000 description 1
231100000330 serious eye damage Toxicity 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
238000012876 topography Methods 0.000 description 1
210000001585 trabecular meshwork Anatomy 0.000 description 1
230000007704 transition Effects 0.000 description 1
230000004304 visual acuity Effects 0.000 description 1
230000004393 visual impairment Effects 0.000 description 1
239000002699 waste material Substances 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Images

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/147—Implants to be inserted in the stroma for refractive correction, e.g. ring-like implants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
- A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir

Landscapes

Health & Medical Sciences (AREA)
Ophthalmology & Optometry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Heart & Thoracic Surgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Transplantation (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Oral & Maxillofacial Surgery (AREA)
Surgery (AREA)
Prostheses (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

JP2003520429A 2001-08-03 2002-08-02 緑内障および老眼の治療のための方法および強膜内インプラント Expired - Fee Related JP4346438B2 (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US31002701P	2001-08-03	2001-08-03
PCT/US2002/024646 WO2003015667A1 (fr)	2001-08-03	2002-08-02	Methode et implant intra-scleral pour le traitement du glaucome et de la presbyopie

Publications (2)

Publication Number	Publication Date
JP2005508213A JP2005508213A (ja)	2005-03-31
JP4346438B2 true JP4346438B2 (ja)	2009-10-21

Family

ID=33510228

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2003520429A Expired - Fee Related JP4346438B2 (ja)	2001-08-03	2002-08-02	緑内障および老眼の治療のための方法および強膜内インプラント

Country Status (6)

Country	Link
EP (1)	EP1418864A4 (fr)
JP (1)	JP4346438B2 (fr)
KR (1)	KR20040024873A (fr)
CA (1)	CA2455120A1 (fr)
IL (1)	IL160037A0 (fr)
WO (1)	WO2003015667A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2014087650A (ja) *	2006-03-31	2014-05-15	Qlt Inc	薬物治療用鼻涙排液系インプラント

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040225250A1 (en)	2003-05-05	2004-11-11	Michael Yablonski	Internal shunt and method for treating glaucoma
US7291125B2 (en)	2003-11-14	2007-11-06	Transcend Medical, Inc.	Ocular pressure regulation
AU2005338015C1 (en) *	2005-10-31	2010-11-18	Life Spring Biotech Co., Ltd.	Scleral buckle band and method for making it
EP1979023B1 (fr)	2006-01-17	2015-07-22	Transcend Medical, Inc.	Dispositif de traitement de glaucome
EP1978892B1 (fr)	2006-01-17	2017-11-15	Novartis Ag	Dispositif de traitement d'administration de medicament
ES2964952T3 (es) *	2006-07-11	2024-04-10	Refocus Group Inc	Prótesis escleral para el tratamiento de la presbicia y otros trastornos oculares
WO2009012406A1 (fr)	2007-07-17	2009-01-22	Transcend Medical, Inc.	Implant oculaire avec référence de capacités d'expansion d'hydrogel pour document prioritaire
JP5323073B2 (ja) *	2007-08-02	2013-10-23	リフォーカスグループ、インコーポレイテッド	老眼及び他の眼疾患を治療するためのクロスバーを有する強膜プロテーゼ
DE102008021842A1 (de)	2008-04-30	2009-11-05	Tesa Se	Polyolefinfolie und Verwendung derselben
US8617139B2 (en)	2008-06-25	2013-12-31	Transcend Medical, Inc.	Ocular implant with shape change capabilities
GB2464981A (en) *	2008-11-01	2010-05-05	Univ Dundee	Pressure sensor for measuring intraocular pressure that can be worn on the eye.
EP3735947B1 (fr)	2009-01-28	2022-05-04	Alcon Inc.	Système d'implantation pour un implant oculaire
US8529492B2 (en)	2009-12-23	2013-09-10	Trascend Medical, Inc.	Drug delivery devices and methods
WO2011155916A1 (fr) *	2010-06-11	2011-12-15	Damiano Richard E	Dispositif d'amélioration pour la lecture pour prévenir et traiter la presbytie de l'œil
WO2013011511A1 (fr)	2011-07-18	2013-01-24	Mor Research Applications Ltd.	Dispositif pour l'ajustement de la tension intraoculaire
US10085633B2 (en)	2012-04-19	2018-10-02	Novartis Ag	Direct visualization system for glaucoma treatment
US9241832B2 (en)	2012-04-24	2016-01-26	Transcend Medical, Inc.	Delivery system for ocular implant
EP2895123B1 (fr)	2012-09-17	2017-06-07	Novartis Ag	Dispositifs d'implant oculaire expansible
US9763829B2 (en)	2012-11-14	2017-09-19	Novartis Ag	Flow promoting ocular implant
US9987163B2 (en)	2013-04-16	2018-06-05	Novartis Ag	Device for dispensing intraocular substances
EP3541323A4 (fr) *	2016-12-23	2020-08-05	Refocus Group, Inc.	Prothèse sclérale à surface(s) dentelée(s) ou autre(s) destinée à être retenue dans un tissu scléral, destinée à traiter la presbytie

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5322691A (en) *	1986-10-02	1994-06-21	Sohrab Darougar	Ocular insert with anchoring protrusions
US4863457A (en) *	1986-11-24	1989-09-05	Lee David A	Drug delivery device
US4946436A (en) *	1989-11-17	1990-08-07	Smith Stewart G	Pressure-relieving device and process for implanting
US5178604A (en)	1990-05-31	1993-01-12	Iovision, Inc.	Glaucoma implant
US5466233A (en) *	1994-04-25	1995-11-14	Escalon Ophthalmics, Inc.	Tack for intraocular drug delivery and method for inserting and removing same
US6102045A (en)	1994-07-22	2000-08-15	Premier Laser Systems, Inc.	Method and apparatus for lowering the intraocular pressure of an eye
US5558630A (en) *	1994-12-30	1996-09-24	Fisher; Bret L.	Intrascleral implant and method for the regulation of intraocular pressure
US5968058A (en) *	1996-03-27	1999-10-19	Optonol Ltd.	Device for and method of implanting an intraocular implant
US6007578A (en)	1997-10-08	1999-12-28	Ras Holding Corp	Scleral prosthesis for treatment of presbyopia and other eye disorders
US6079417A (en)	1999-03-23	2000-06-27	Fugo; Richard J.	Method of altering the shape of the cornea of the eye

2002
- 2002-08-02 KR KR10-2004-7001249A patent/KR20040024873A/ko not_active Ceased
- 2002-08-02 JP JP2003520429A patent/JP4346438B2/ja not_active Expired - Fee Related
- 2002-08-02 EP EP02768411A patent/EP1418864A4/fr not_active Withdrawn
- 2002-08-02 IL IL16003702A patent/IL160037A0/xx unknown
- 2002-08-02 CA CA002455120A patent/CA2455120A1/fr not_active Abandoned
- 2002-08-02 WO PCT/US2002/024646 patent/WO2003015667A1/fr not_active Ceased

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2014087650A (ja) *	2006-03-31	2014-05-15	Qlt Inc	薬物治療用鼻涙排液系インプラント
US12226525B2 (en)	2006-03-31	2025-02-18	Mati Therapeutics, Inc.	Nasolacrimal drainage system implants for drug therapy

Also Published As

Publication number	Publication date
EP1418864A4 (fr)	2009-07-01
WO2003015667A8 (fr)	2004-12-16
JP2005508213A (ja)	2005-03-31
CA2455120A1 (fr)	2003-02-27
KR20040024873A (ko)	2004-03-22
WO2003015667A1 (fr)	2003-02-27
EP1418864A1 (fr)	2004-05-19
IL160037A0 (en)	2004-06-20

Legal Events

Date	Code	Title	Description
2005-07-08	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050707
2008-06-06	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080605
2008-08-30	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080829
2008-09-08	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080905
2008-10-04	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20081003
2008-10-14	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20081010
2008-10-31	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081030
2008-11-27	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081126
2009-02-26	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090225
2009-03-05	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090304
2009-03-25	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090324
2009-04-01	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090331
2009-04-10	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090409
2009-05-13	TRDD	Decision of grant or rejection written
2009-05-18	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090515
2009-05-21	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01
2009-06-16	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090615
2009-06-19	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090618
2009-07-23	A61	First payment of annual fees (during grant procedure)	Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090714
2009-07-24	R150	Certificate of patent or registration of utility model	Free format text: JAPANESE INTERMEDIATE CODE: R150
2009-07-27	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20120724 Year of fee payment: 3
2012-07-24	LAPS	Cancellation because of no payment of annual fees

Publication	Publication Date	Title
JP4346438B2 (ja)	2009-10-21	緑内障および老眼の治療のための方法および強膜内インプラント
US8267995B2 (en)	2012-09-18	Method and intra sclera implant for treatment of glaucoma and presbyopia
CA2493010C (fr)	2011-09-13	Dispositif de drainage uveoscleral
US20070219632A1 (en)	2007-09-20	Method and intra-sclera implant for treatment of glaucoma and presbyopia
WO2008039397A2 (fr)	2008-04-03	Méthode et implant intra-scléral servant à traiter le glaucome et la presbytie
KR100732262B1 (ko)	2007-06-25	약물 전달 장치
US10342703B2 (en)	2019-07-09	Glaucoma drainage implant
US8366653B2 (en)	2013-02-05	Intraocular pressure regulating device
JP3088746B2 (ja)	2000-09-18	緑内障インプラント
EP2521517B1 (fr)	2016-10-05	Dispositif ophtalmique chirurgical
JP2002541976A (ja)	2002-12-10	緑内障を治療するためのステント装置および方法
KR20090102810A (ko)	2009-09-30	시력 결함을 억제하기 위한 약물 전달 임플란트
WO1993020783A1 (fr)	1993-10-28	Implant pour le traitement du glaucome
MXPA04001076A (es)	2005-02-17	Metodo e implante intraescleral para tratamiento de glaucoma y presbicia.
KR102844717B1 (ko)	2025-08-12	안압 조절용 방수유출장치
HK1069524A (en)	2005-05-27	Method and intra sclera implant for treatment of glaucoma and presbyopia
HK1146799A (en)	2011-07-15	Uveoscleral drainage device